GLP-1 refill delay or missed dose? Questions to ask before you run out

The risky moment is often before the box is empty

A GLP-1 refill delay can turn into several different problems at once: a missed dose, a pharmacy substitution question, an insurance timing problem, a restart decision, or pressure to buy from a less transparent source. The useful move is to ask the prescribing team what to do before you run out, not after an online offer starts looking convenient.

Do not improvise a restart plan

FDA-approved labels include medication-specific missed-dose instructions, and those instructions are not the same for every product or format. Wegovy injection labeling describes different steps depending on how close the next scheduled dose is and notes that after two or more missed weekly injection doses, reinitiation with dose escalation may be needed to reduce gastrointestinal reactions. Zepbound labeling gives its own missed-dose timing. Treat those labels as a reason to call the clinician or pharmacist, not as a substitute for individualized advice.

• Ask whether your last dose date changes the next dose, restart, or escalation plan.
• Ask who confirms the plan: prescriber, pharmacist, supervising clinician, or another team member.
• Ask what symptoms should delay a restart or trigger urgent medical attention.
• If you have diabetes or use other glucose-lowering medicines, ask for explicit medication and glucose-monitoring instructions.

Separate supply delay from sourcing risk

FDA has said semaglutide and tirzepatide injection shortages were resolved at the national level, while patients may still see localized supply disruptions as products move through manufacturers, distributors, and pharmacies. A localized delay does not automatically make an unapproved, counterfeit, or poorly explained alternative safer. Ask the clinic to explain the exact product, pharmacy, prescription path, and contingency plan before accepting any switch.

Use the delay to test provider support

A credible program should have a clear refill workflow instead of leaving you to search social media or customer-support scripts. Ask when refill requests are reviewed, how prior authorization renewals are tracked, whether the team can transfer the prescription to another pharmacy, and what happens if the pharmacy cannot fill the medication before the next scheduled dose.

• How many days before the expected refill should I contact the clinic?
• Who checks whether the pharmacy has the product or needs a transfer?
• Will the clinic document the medication, dose, last fill date, and pharmacy in writing?
• Does the program charge extra for refill troubleshooting, prior authorization renewal, or pharmacy transfer support?

Be careful with compounded or online substitutions

FDA has warned about unapproved GLP-1 products used for weight loss, counterfeit Ozempic, illegal online sales, and dosing errors tied to compounded injectable products. FDA also announced warning letters to telehealth companies over false or misleading claims about compounded GLP-1 products. If a refill delay leads to a new offer, slow down and verify whether it is FDA-approved, compounded, legally prescribed, dispensed by a state-licensed pharmacy, and explained by a licensed clinician.

Write down the answer before the next delay

After the refill issue is solved, ask the care team for a simple written plan: how early to request refills, who handles pharmacy transfers, what to do after one missed dose, what to do after multiple missed doses, how insurance renewals are handled, and when symptoms or diabetes history require a same-day clinician response. That plan is part of care quality, not an administrative extra.